JP2009523732A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523732A5
JP2009523732A5 JP2008550455A JP2008550455A JP2009523732A5 JP 2009523732 A5 JP2009523732 A5 JP 2009523732A5 JP 2008550455 A JP2008550455 A JP 2008550455A JP 2008550455 A JP2008550455 A JP 2008550455A JP 2009523732 A5 JP2009523732 A5 JP 2009523732A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
defined above
aryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008550455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523732A (ja
Filing date
Publication date
Priority claimed from US11/331,180 external-priority patent/US7868037B2/en
Application filed filed Critical
Priority claimed from PCT/US2007/000996 external-priority patent/WO2007084435A2/fr
Publication of JP2009523732A publication Critical patent/JP2009523732A/ja
Publication of JP2009523732A5 publication Critical patent/JP2009523732A5/ja
Withdrawn legal-status Critical Current

Links

JP2008550455A 2006-01-13 2007-01-16 C型肝炎の治療方法 Withdrawn JP2009523732A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75852706P 2006-01-13 2006-01-13
US11/331,180 US7868037B2 (en) 2004-07-14 2006-01-13 Methods for treating hepatitis C
US92148307P 2007-01-13 2007-01-13
PCT/US2007/000996 WO2007084435A2 (fr) 2006-01-13 2007-01-16 Procedes de traitement de l’hepatite c

Publications (2)

Publication Number Publication Date
JP2009523732A JP2009523732A (ja) 2009-06-25
JP2009523732A5 true JP2009523732A5 (fr) 2010-03-04

Family

ID=38283923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550455A Withdrawn JP2009523732A (ja) 2006-01-13 2007-01-16 C型肝炎の治療方法

Country Status (2)

Country Link
JP (1) JP2009523732A (fr)
WO (1) WO2007084435A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2064181A1 (fr) 2006-12-22 2009-06-03 Schering Corporation Dérivés condensés à 4,5 noyaux destinés au traitement ou à la prévention du vhc et des infections virales associées
MX2009006877A (es) 2006-12-22 2009-09-28 Schering Corp Derivados indolicos con anillo unido en las posiciones 5,6 y metodos de uso de los mismos.
AU2007339382B2 (en) 2006-12-22 2013-05-02 Merck Sharp & Dohme Llc 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
PE20090995A1 (es) * 2007-08-29 2009-08-03 Schering Corp Derivados indolicos 2,3-sustituidos como inhibidores del virus de la hepatitis c (vhc)
EP2195317B1 (fr) * 2007-08-29 2012-01-18 Schering Corporation Dérivés d'azaindoles substitués en 2 et 3 destinés au traitement d'infections virales
KR20100067652A (ko) 2007-08-29 2010-06-21 쉐링 코포레이션 치환된 인돌 유도체 및 이의 사용방법
EP2222660B1 (fr) 2007-11-16 2014-03-26 Merck Sharp & Dohme Corp. Dérivés d'indole à substitution hétérocyclique en position 3 et leurs procédés d'utilisation
US8377928B2 (en) 2007-11-16 2013-02-19 Merck Sharp & Dohme Corp. 3-aminosulfonyl substituted indole derivatives and methods of use thereof
JP5580814B2 (ja) 2008-06-13 2014-08-27 メルク・シャープ・アンド・ドーム・コーポレーション 3環式インドール誘導体およびその使用方法
TWI438200B (zh) * 2009-02-17 2014-05-21 必治妥美雅史谷比公司 C型肝炎病毒抑制劑
EP2545050B1 (fr) * 2010-03-10 2014-08-13 Bristol-Myers Squibb Company Composés destinés au traitement de l'hépatite c
US9877957B2 (en) 2014-09-05 2018-01-30 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
WO2016036638A1 (fr) 2014-09-05 2016-03-10 Merck Sharp & Dohme Corp. Dérivés d'isoquinoline utiles en tant qu'inhibiteurs de diacylglycéride o-acyltransférase 2
WO2016036633A1 (fr) 2014-09-05 2016-03-10 Merck Sharp & Dohme Corp. Dérivés de tétrahydroisoquinoléine utiles en tant qu'inhibiteurs de diacylglycéride o-acyltransférase 2
KR20190085035A (ko) 2016-11-18 2019-07-17 머크 샤프 앤드 돔 코포레이션 디아실글리세리드 o-아실트랜스퍼라제 2의 억제제로서 유용한 인돌 유도체
KR20190078646A (ko) 2016-11-18 2019-07-04 머크 샤프 앤드 돔 코포레이션 디아실글리세리드 o-아실트랜스퍼라제 2의 억제제로서 유용한 인다졸 유도체
BR112021006488A2 (pt) 2018-10-05 2021-07-06 Annapurna Bio Inc compostos e composições para o tratamento de condições associadas com atividade do receptor apj

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (fr) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びhcv阻害剤としてのその使用
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) * 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
GB0323845D0 (en) * 2003-10-10 2003-11-12 Angeletti P Ist Richerche Bio Chemical compounds,compositions and uses
BRPI0511834A (pt) * 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c

Similar Documents

Publication Publication Date Title
JP2009523732A5 (fr)
AR113903A2 (es) Derivados fungicidas de pirazol carboxamidas
JP2013531029A5 (fr)
AR067946A1 (es) Imidazoles biciclicos fusionados
RU2016125306A (ru) Новые пестицидные соединения и применения
RU2015131149A (ru) N-(замещенные)-5-фтор-4-имино-3-метил-2-оксо-3,4-дигидропиримидин-1(2н)-карбоксамидные производные
PE20181304A1 (es) Derivados de indol n-sustituidos como moduladores de los receptores de pge2
PE20141075A1 (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
JP2011524422A5 (fr)
RU2010126105A (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства
AR094929A1 (es) Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
AR087288A1 (es) Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a
RU2010106393A (ru) Новые микробиоциды
AR057062A1 (es) Moduladores de aminoquinolina y aminoquinazolina quinasa
RU2015131095A (ru) Производные n-(замещенного)-5-фтор-4-имино-3-метил-2-оксо-3,4-дигидропиримидин-1(2н)-карбоксилата
RU2011116160A (ru) Производные пиридина, замещенные гетероциклическим кольцом и y-глутамиламиногруппой и содержащие их противогрибковые средства
CA2539349A1 (fr) Naphtyridones et quinolones 7-amino alkylidenyl-heterocycliques
EA022420B1 (ru) Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5)
RU2010101004A (ru) Новые микробиоциды
RU2016118399A (ru) Производные 4-аминометилбензойной кислоты
CA2626402A1 (fr) Inhibiteurs du canal potassique
AR061419A1 (es) Compuestos de piridil amida sustituidos como moduladores del receptor de histamida h3
AR078783A1 (es) Compuestos heterociclicos pesticidas
AR077819A1 (es) Compuestos heterociclicos antagonistas de esfingosina -1-fosfato (sip)